LCTX vs AMGN: Which Stock is Better?
Side-by-side comparison of Lineage Cell Therapeutics Inc and Amgen Inc in 2026
LCTX
Lineage Cell Therapeutics Inc
$1.71
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | LCTX | AMGN | Winner |
|---|---|---|---|
| Market Cap | $425.94M | $191.53B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.46 | AMGN |
| Revenue Growth | 1.3% | 0.1% | LCTX |
| Gross Margin | -22.8% | 70.8% | AMGN |
Analyze LCTX
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCTX or AMGN a better investment?
Comparing LCTX and AMGN: Lineage Cell Therapeutics Inc has a market cap of $425.94M while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCTX and AMGN?
LCTX (Lineage Cell Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCTX or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCTX or AMGN?
LCTX has higher revenue growth at 1.3% vs 0.1% for AMGN.
Which company is more profitable: LCTX or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -22.8% for LCTX.
Which is the larger company: LCTX or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $425.94M for LCTX.
Should I buy LCTX or AMGN in 2026?
Both LCTX and AMGN have investment merit. LCTX trades at $1.71 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCTX and AMGN stock?
Key differences: Market Cap ($425.94M vs $191.53B), P/E Ratio (N/A vs 24.6x), Revenue Growth (1.3% vs 0.1%), Gross Margin (-22.8% vs 70.8%).